Literature DB >> 22964960

Aggressive surgical management of recurrent lymph node and pancreatic head metastases of resected fibrolamellar hepatocellular carcinoma: a case report.

Maciej Wojcicki1, Jerzy Lubikowski, Mariola Post, Tomasz Chmurowicz, Anna Wiechowska-Kozlowska, Marek Krawczyk.   

Abstract

CONTEXT: Fibrolamellar hepatocellular carcinoma is a rare liver tumor with the propensity to metastasize to the lymph nodes months or years after initial surgery. However, its metastatic spread to the pancreas was previously reported only in a child. CASE REPORT: We present an unusual case of a young female patient who was repeatedly treated by surgical excision of abdominal and mediastinal lymph node recurrences between 2 and 6 years after left hepatic lobectomy for fibrolamellar hepatocellular carcinoma. At 8 years following her initial surgery, the patient was diagnosed with pancreatic head metastasis and a pancreaticoduodenectomy was performed. Postoperative course was uneventful and the patient did not experience recurrence within the last 18 months.
CONCLUSION: The metastasis of fibrolamellar hepatocellular carcinoma to the pancreas is highly exceptional but possible and its excision appears warranted as well.

Entities:  

Mesh:

Year:  2012        PMID: 22964960     DOI: 10.6092/1590-8577/839

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


  6 in total

1.  Cytoreductive Surgery and HIPEC for Recurrent Fibrolamellar Hepatocellular Carcinoma with Peritoneal Carcinomatosis.

Authors:  D Kyziridis; A Kalakonas; K Zarambouka; C Hristakis; Antonios-Apostolos K Tentes
Journal:  J Gastrointest Cancer       Date:  2020-03

Review 2.  Pancreatic adenocarcinosarcoma of monoclonal origin: a case report.

Authors:  Hyun Seon Kim; Jin Il Kim; Minyoung Jeong; Jae Hyun Seo; Il Kyu Kim; Dae Young Cheung; Tae-Jung Kim; Chang Suk Kang
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

3.  Pancreaticoduodenectomy for hepatic portal lymph node metastasis after hepatic resection for hepatocellular carcinoma: A clinical case report.

Authors:  Tran Que Son; Tran Hieu Hoc; Vu Duc Long; Nguyen Toan Thang; Tran Thu Huong; Pham Van Tuyen
Journal:  Int J Surg Case Rep       Date:  2021-04-27

4.  Metastatic Fibrolamellar Hepatocellular Carcinoma to the Pancreas.

Authors:  Nicolas A Villa; Rahul Pannala; Douglas O Faigel; Danielle J Haakinson; Nitin Katariya; Ramesh Ramanathan; Dawn Jaroszewski; Thomas K Lidner; Thomas Byrne
Journal:  Case Rep Gastroenterol       Date:  2015-07-29

Review 5.  Fibrolamellar hepatocellular carcinoma: current clinical perspectives.

Authors:  Kelly J Lafaro; Timothy M Pawlik
Journal:  J Hepatocell Carcinoma       Date:  2015-10-09

6.  Clinical features and surgical outcomes of fibrolamellar hepatocellular carcinoma: retrospective analysis of a single-center experience.

Authors:  Anastasia Lemekhova; Daniel Hornuss; Georgios Polychronidis; Philipp Mayer; Christian Rupp; Thomas Longerich; Karl-Heinz Weiss; Markus Büchler; Arianeb Mehrabi; Katrin Hoffmann
Journal:  World J Surg Oncol       Date:  2020-05-12       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.